Abstract:OBJECTIVETo predict the therapeutic efficacy of oral rehydration salts (ORS) by quantifying changes in heart rate during the head-up test (HUT) in children with postural tachycardia syndrome (POTS).METHODFifty-four children from Peking University First Hospital during July 2005 to September 2013 were enrolled into POTS group. Twenty healthy children were enrolled in this study as the control group. Children with POTS were treated with ORS and successfully followed up. HUT test was done before and at the end of the treatment. POTS children were further divided into responding group and the non-responding group depending on if the symptom scores were reduced by 50% or greater after the treatment. The heart rate, systolic blood pressure (SBP) and diastolic blood pressure (DBP) changes during the HUT test were analyzed between the control group and the POTS patients. A receiver operating characteristic (ROC) curve was used to analyze the predictive value of the increase in heart rates (from the supine to upright) and the maximum upright heart rate in 10 minutes after ORS treatment.RESULTPOTS children were 6-17 (11.3 ± 3.0) years old and the control group children were 10-12 (11.0 ± 0.8) years old. The changes of the heart rate during the HUT was different between the POTS patients and the controls ((41 ± 10) vs. (20 ± 7) beats/min, t = -10.441, P = 0.000) . There was no significant difference between the two groups in the maximum upright heart rate in 10 minutes during the HUT ( (117 ± 12) vs. (114 ± 8) beats/min, t = -1.322, P = 0.192) . The symptom scores were reduced compared with those before treatment ((3.2 ± 1.8) vs. (5.7 ± 2.0), t = 10.958, P < 0.001) and the heart rate changes from supine to upright were decreased in 30 patients ((33 ± 11) vs. (41 ± 11) beats/min, t = 2.956, P = 0.006). Compared with the non-responding group (28 cases), the heart rate change during the HUT test was great in the responding group (26 cases) before treatment ((46 ± 10) vs. (37 ± 9) beats/min, t = -3.582, P = 0.001), and the maximum upright heart rate in 10 minutes was also high in the responding group ( (122 ± 12) vs. (113 ± 10) beats/min, t = -2.693, P = 0.010). The ROC curve showed that ORS for children with POTS would be predicted to be effective when the pre-treatment increase of heart rate was 41 beats/min (sensitivity 72% and specificity 70%), or when the maximum upright heart rate in 10 minutes was 123 beats/min before treatment (sensitivity 48% specificity 56%). When the two indices were used together, sensitivity was 84% and specificity was 56%.CONCLUSIONThe changes in heart rate during the HUT was useful in predicting the response to ORS in children with POTS.

Predictive value of upright blood pressure change for long-term prognosis of children with postural tachycardia syndrome treated with midodrine hydrochloride

Difference Between Supine and Upright Blood Pressure Associates to the Efficacy of Midodrine on Postural Orthostatic Tachycardia Syndrome (POTS) in Children

[Predictive Value of Baseline Plasma Midregional Fragment of Pro-Adrenomedullin Level on Long-Term Outcome of Postural Tachycardia Syndrome Children Treated with Midodrine Hydrochloride].

The Follow-Up Study on the Treatment of Children with Postural Orthostatic Tachycardia Syndrome

A time-effect analysis of postural orthostatic tachycardia syndrome treated with midodrine hydrochloride in children

A signal center follow-up study on the treatment of postural tachycardia syndrome in children

[Effect of Selective Alpha1 Receptor Agonist in the Treatment of Children with Postural Orthostatic Tachycardia Syndrome].

Midodrine hydrochloride is effective in the treatment of children with postural orthostatic tachycardia syndrome.

The Prognostic Meaning of Biomarkers and Hemodynamic Parameters in the Postural Tachycardia Syndrome Children Treated with Midodrine Hydrochloride

[Evaluation of the Changes in Heart Rate During Head-Up Test Predicting the Efficacy of Oral Rehydration Salts on Postural Tachycardia Syndrome in Children].

Flow-mediated vasodilation as a predictor of therapeutic response to midodrine hydrochloride in children with postural orthostatic tachycardia syndrome.

Therapies for Postural Tachycardia Syndrome in Children

Plasma copeptin and therapeutic effectiveness of midodrine hydrochloride on postural tachycardia syndrome in children.

P29 Children suffering from postural orthostatic tachycardia syndrome with a marked increase in erythrocytic hydrogen sulfide have a better therapeutic response to midodrine hydrochloride

Hemocytometric Measures Predict the Efficacy of Oral Rehydration for Children with Postural Tachycardia Syndrome.

Midregional Pro-Adrenomedullin As a Predictor for Therapeutic Response to Midodrine Hydrochloride in Children with Postural Orthostatic Tachycardia Syndrome.

Postural Orthostatic Tachycardia Syndrome with Increased Erythrocytic Hydrogen Sulfide and Response to Midodrine Hydrochloride

Prognostic value of heart rate and blood pressure in children and adolescents with postural tachycardia syndrome

Baseline left ventricular ejection fraction associated with symptom improvements in both children and adolescents with postural tachycardia syndrome under metoprolol therapy

Orthostatic plasma norepinephrine level as a predictor for therapeutic response to metoprolol in children with postural tachycardia syndrome

Risk Factors for Postural Tachycardia Syndrome in Children and Adolescents